Female colorectal cancer 19 percent less likely for each additional 10 ng of vitamin D (17 studies) – June 2018

Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts

Journal of the National Cancer Institute, https://doi.org/10.1093/jnci/djy087
Marjorie L McCullough Emilie S Zoltick Stephanie J Weinstein Veronika Fedirko Molin Wang Nancy R Cook A Heather Eliassen Anne Zeleniuch-Jacquotte Claudia Agnoli Demetrius JNCI:


Background
Experimental and epidemiological studies suggest a protective role for vitamin D in colorectal carcinogenesis, but evidence is inconclusive. Circulating 25-hydroxyvitamin D (25(OH)D) concentrations that minimize risk are unknown. Current Institute of Medicine (IOM) vitamin D guidance is based solely on bone health.

Methods
We pooled participant-level data from 17 cohorts, comprising 5706 colorectal cancer case participants and 7107 control participants with a wide range of circulating 25(OH)D concentrations. For 30.1% of participants, 25(OH)D was newly measured. Previously measured 25(OH)D was calibrated to the same assay to permit estimating risk by absolute concentrations. Study-specific relative risks (RRs) for prediagnostic season-standardized 25(OH)D concentrations were calculated using conditional logistic regression and pooled using random effects models.

Results
Compared with the lower range of sufficiency for bone health (50–<62.5 nmol/L), deficient 25(OH)D (<30 nmol/L) was associated with 31% higher colorectal cancer risk (RR = 1.31, 95% confidence interval CI = 1.05 to 1.62); 25(OH)D above sufficiency (75–<87.5 and 87.5–<100 nmol/L) was associated with 19% (RR = 0.81, 95% CI = 0.67 to 0.99) and 27% (RR = 0.73, 95% CI = 0.59 to 0.91) lower risk, respectively. At 25(OH)D of 100 nmol/L or greater, risk did not continue to decline and was not statistically significantly reduced (RR = 0.91, 95% CI = 0.67 to 1.24, 3.5% of control participants).
Associations were minimally affected when adjusting for body mass index, physical activity, or other risk factors.
For each 25 nmol/L increment in circulating 25(OH)D, colorectal cancer risk was 19% lower in women (RR = 0.81, 95% CI = 0.75 to 0.87) and 7% lower in men (RR = 0.93, 95% CI = 0.86 to 1.00) (two-sided Pheterogeneity by sex = .008).
Associations were inverse in all subgroups, including colorectal subsite, geographic region, and season of blood collection.

Conclusions
Higher circulating 25(OH)D was related to a statistically significant, substantially lower colorectal cancer risk in women and non–statistically significant lower risk in men. Optimal 25(OH)D concentrations for colorectal cancer risk reduction, 75-100 nmol/L, appear higher than current IOM recommendations.

 Download the PDF from the public domain (was written by Govt employees) from VitaminDWiki

2532 visitors, last modified 18 Jul, 2018,
Printer Friendly Follow this page for updates